All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

324

Reset

324 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BL-M14D1Phase 32 trials

    SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma

  • EU-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • IparomlimabPhase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

  • JAB-3312Phase 32 trials

    Allist Pharmaceuticals, Inc. · KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer

  • JK-1201IPhase 32 trials

    JenKem Technology Co., Ltd. · Glioblastoma Multiforme (GBM), Small Cell Lung Cancer

  • JYP0322Phase 32 trials

    Guangzhou JOYO Pharma Co., Ltd · Non Small Cell Lung Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)

  • NeladalkibNVL-655Phase 32 trials

    Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor

  • OBI-821OBI-833Phase 32 trials

    OBI Pharma, Inc · Triple Negative Breast Cancer, Non-small Cell Lung Cancer

  • OciperlimabBGB-A1217Phase 32 trials

    BeOne Medicines (BeiGene) · Non Small Cell Lung Cancer, Advanced Malignancies

  • OSE2101Phase 32 trials

    OSE Immunotherapeutics · Patients With Non-Small Cell Lung Cancer, Solid Advanced Tumor, Lymphoma

  • PF-07248144Phase 32 trials

    Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • PF-08046054SGN-PDL1VPhase 32 trials

    Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma

  • Precemtabart tocentecanPrecem-TcT, M9140Phase 32 trials

    EMD Serono Research & Development Institute, Inc. · Metastatic Colorectal Cancer, Solid Tumors, Gastric Cancer

  • SetidegrasibASP3082Phase 32 trials

    Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma

  • SugemalimabPhase 32 trials

    Akeso · NSCLC (Non-small Cell Lung Cancer), Extranodal NK/T-cell Lymphoma

  • TGRX-326once a dayPhase 32 trials

    Shenzhen TargetRx Co., Ltd. · Non-small Cell Lung Cancer, Non Small Cell Lung Cancer

  • TQB2450Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer

  • TuvonralimabPhase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

  • UliledlimabPhase 32 trials

    TJ Biopharma Co., Ltd. · Non Small Cell Lung Cancer

  • US-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • Sichuan Baili Pharmaceutical Co., Ltd. · Squamous Non-small-cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer

  • VT3989Phase 32 trials

    Vivace Therapeutics, Inc · Pleural Mesothelioma, Mesothelioma, Solid Tumor, Adult

  • ABBV-1480Phase 31 trial

    AbbVie · Non-Small Cell Lung Cancer

  • adebelizumabPhase 31 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced or Metastatic Non-small Cell Lung Cancer

  • Alflutinib MesylatePhase 31 trial

    Allist Pharmaceuticals, Inc. · Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer

  • SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma

  • Atigotatug+NivolumabBMS-986489Phase 31 trial

    Bristol Myers Squibb · Extensive-Stage Small Cell Lung Cancer

  • FHND9041Phase 31 trial

    Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Non Small Cell Lung Cancer

  • HLX17Phase 31 trial

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer

  • HS-20117PM1080Phase 31 trial

    Hansoh BioMedical R&D Company · Non-Squamous Non-Small Cell Lung Cancer

  • IcotinibPhase 31 trial

    Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy

  • IptilimumabPhase 31 trial

    InSightec · Brain Tumor, Non Small Cell Lung Cancer

  • JMKX001899Phase 31 trial

    Jemincare · NSCLC (Non-small Cell Lung Cancer)

  • MB12Proposed Pembrolizumab BiosimilarPhase 31 trial

    mAbxience Research S.L. · Non Squamous Non Small Cell Lung Cancer

  • PaxlitaxelPhase 31 trial

    Akeso · Advanced Squamous Non Small Cell Lung Cancer

  • PlinabulinPhase 31 trial

    BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance

  • QL1604Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer

  • RilogrotugPhase 31 trial

    AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome

  • SB27Phase 31 trial

    Samsung Bioepis Co., Ltd. · Non-small Cell Lung Cancer Stage IV

  • SH-1028Phase 31 trial

    Nanjing Sanhome Pharmaceutical, Co., Ltd. · Non-small Cell Lung Cancer

  • YK-209APhase 31 trial

    Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

  • SHR-9839Phase 28 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • SKB571Phase 26 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors

  • Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials

    Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)

  • GFH276Phase 25 trials

    Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)

  • PalacaparibAZD9574Phase 25 trials

    AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • SHR-1826Phase 25 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer

NewerPage 3 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.